相关实验视频

Updated: Jul 28, 2025

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

基于纳米架构的针对性输送系统用于糖尿病病:一篇评论

Aruna Rawat¹, Vikas Jhawat¹, Rohit Dutt²

¹Department of Pharmaceutical Science, School of Medical and Allied Science, GD Goenka University, Gurugram, Haryana, India.

Current drug targets

|June 2, 2023

概括

纳米技术为治疗糖尿病及其并发症糖尿病病提供了一个有前途的解决方案. 植物性抗糖尿病分子的纳米级配方提高了治疗效率和患者的服从性.

科学领域:

纳米医学是一种纳米医学.
药理学药理学是指药理学的学科.
内分泌学在内分泌学.

背景情况:

糖尿病,以高血糖为特征,往往导致糖尿病病 (DN).
目前对DN的管理策略包括心血管风险降低,血糖控制,血压管理和氨酸-血管酶系统 (RAS) 阻塞.
虽然有效地延迟了DN的发病,但现有的治疗方法无法阻止它的进展.

结论:

纳米药物是一种潜在的战略,可以最大限度地提高植物抗糖尿病剂的治疗效益.
进一步的临床研究对于开发植物性抗糖尿病分子的有效纳米形式至关重要.
推进纳米医学对于对抗糖尿病及其并发症如糖尿病病至关重要.

关键词:

糖尿病脏病糖尿病脏病在糖尿病中,糖尿病是血糖性糖尿病.过高血糖症 (hyperglycemia) 是一种纳米建筑师纳米建筑师病理生理学病理生理学可溶性增强提高可溶性

更多相关视频

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Published on: May 10, 2022

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres

Published on: November 5, 2016

相关概念视频